We are live on ! Find out more
BFO

Boston Family Office Portfolio holdings

AUM $1.5B
1-Year Est. Return 11.68%
This Fund
S&P 500
This Quarter Est. Return
+2.6%
1 Year Est. Return
+11.68%
3 Year Est. Return
+44.44%
5 Year Est. Return
+55.04%
10 Year Est. Return
+251.5%
AUM
$772M
AUM Growth
+$12.8M
Cap. Flow
-$2.04M
Cap. Flow %
-0.26%
Top 10 Hldgs %
21.05%
Holding
257
New
18
Increased
58
Reduced
106
Closed
11

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$3.64M
2
SPGI icon
S&P Global
SPGI
+$3.23M
3
BKU icon
Bankunited
BKU
+$1.98M
4
NWL icon
Newell Brands
NWL
+$1.44M
5
SRCL
Stericycle Inc
SRCL
+$1.37M

Sector Composition

Rank Sector Weight
1 Healthcare 18.68%
2 Industrials 14%
3 Consumer Staples 11.82%
4 Technology 11.65%
5 Financials 7.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NKE icon
26
Nike
NKE
$63.1B
$9.29M 1.2%
168,268
+1,102
+0.7% +$62.8K
PEP icon
27
PepsiCo
PEP
$190B
$8.7M 1.13%
82,099
-892
-1% -$92K
FRC
28
DELISTED
First Republic Bank
FRC
$8.66M 1.12%
123,809
+2,241
+2% +$155K
SYK icon
29
Stryker
SYK
$130B
$7.34M 0.95%
61,255
-275
-0.4% -$30.7K
AFL icon
30
Aflac
AFL
$64.6B
$6.81M 0.88%
188,646
-24,914
-12% -$851K
MMM icon
31
3M
MMM
$91.2B
$6.75M 0.88%
46,137
-117
-0.3% -$16.5K
MRK icon
32
Merck
MRK
$315B
$6.35M 0.82%
115,450
-3,089
-3% -$164K
PM icon
33
Philip Morris
PM
$294B
$6.12M 0.79%
60,155
-500
-0.8% -$49.9K
PH icon
34
Parker-Hannifin
PH
$125B
$5.99M 0.78%
55,474
WY icon
35
Weyerhaeuser
WY
$18B
$5.98M 0.78%
201,021
+10,168
+5% +$313K
MKC icon
36
McCormick & Company Non-Voting
MKC
$13.9B
$5.98M 0.77%
112,100
-970
-0.9% -$47.3K
MSFT icon
37
Microsoft
MSFT
$3.64T
$5.98M 0.77%
116,786
-450
-0.4% -$23.4K
PX
38
DELISTED
Praxair Inc
PX
$5.85M 0.76%
52,013
MCD icon
39
McDonald's
MCD
$191B
$5.79M 0.75%
48,076
ABBV icon
40
AbbVie
ABBV
$435B
$5.74M 0.74%
92,671
+93
+0.1% +$5.67K
CVS icon
41
CVS Health
CVS
$134B
$5.74M 0.74%
59,919
-1,239
-2% -$123K
NEE icon
42
NextEra Energy
NEE
$179B
$5.71M 0.74%
175,152
+2,460
+1% +$73.9K
DHR icon
43
Danaher
DHR
$139B
$5.56M 0.72%
81,971
-1,301
-2% -$85.1K
TEVA icon
44
Teva Pharmaceuticals
TEVA
$39.8B
$5.53M 0.72%
110,049
PFE icon
45
Pfizer
PFE
$142B
$5.2M 0.67%
155,530
-2,434
-2% -$77.7K
MON
46
DELISTED
Monsanto Co
MON
$5.15M 0.67%
49,800
-15,506
-24% -$1.54M
LKQ icon
47
LKQ Corp
LKQ
$5.88B
$5.14M 0.67%
162,240
+890
+0.6% +$28.9K
BKU icon
48
Bankunited
BKU
$3.4B
$5.12M 0.66%
166,543
+59,541
+56% +$1.98M
WAB icon
49
Wabtec
WAB
$50B
$4.86M 0.63%
69,126
-194
-0.3% -$15.1K
AMZN icon
50
Amazon
AMZN
$3.04T
$4.84M 0.63%
135,260
-20,380
-13% -$689K

Similar funds

Boston Family Office's Q2 2016 Portfolio in Review

As of Q2 2016, Boston Family Office held 257 positions worth $772M, up 1.7% from $759M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Boston Family Office's Q2 2016 filing shows 18 new, 58 increased, 106 reduced and 11 closed positions. Its largest new stake was S&P Global: 30,095 shares worth $3.23M. The largest sale was MCGRAW-HILL FINANCIAL INC COM, an estimated $3.02M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Industrials and Consumer Staples.

  • Boston Family Office's largest Q2 2016 buy was S&P Global: 30,095 shares worth $3.23M.
  • Boston Family Office added most to Apple in Q2 2016, an estimated $3.64M increase.
  • Boston Family Office's biggest Q2 2016 reduction was GE Aerospace, cutting an estimated $2.42M.
  • Boston Family Office fully exited MCGRAW-HILL FINANCIAL INC COM in Q2 2016, selling an estimated $3.02M.
  • Boston Family Office's ten largest holdings make up 21% of its $772M portfolio in Q2 2016.
  • Boston Family Office opened 18 new positions and closed 11 in Q2 2016.
  • Boston Family Office's portfolio value rose 1.7% quarter-over-quarter to $772M.

Based on Boston Family Office's 13F filing for Q2 2016, filed 4 Aug 2016.